The anti-obesity effects of Lactobacillus casei strain Shirota versus Orlistat on high fat diet-induced obese rats

Food and Nutrition Research

Volumn 59, Issue , 2015, Pages

  Karimi, Golgis ^a   Sabran, Mohd Redzwan ^a   Jamaluddin, Rosita ^a   Parvaneh, Kolsoom ^a   Mohtarrudin, Norhafizah ^a   Ahmad, Zuraini ^a   Khazaai, Huzwah ^a   Khodavandi, Alireza ^b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

High fat diet; Lactobacillus casei strain Shirota; Obesity; Orlistat

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; LEPTIN; PROBIOTIC AGENT; TETRAHYDROLIPSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIET INDUCED OBESITY; FAT MASS; FOOD INTAKE; LACTOBACILLUS CASEI; MALE; NONHUMAN; ORGAN WEIGHT; RAT;

EID: 84958554755     PISSN: 16546628     EISSN: None     Source Type: Journal    
DOI: 10.3402/fnr.v59.29273     Document Type: Article

References (51)

1. An HM, Lee DK, Kim JR, Cha MK, Lee SW, Lim HT, et al. Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids Health Dis 2011; 10: 116.
2. World Health Organization (2015). Obesity and overweight. Fact sheet N8. 311, Media Centre. [Updated January 2015]; Available from: http://www.who.int/mediacentre/factsheets/fs311/en/[cited 12 February 2015].
3. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; 362: 590-9.
4. Golubnitschaja O, Costigliola V. General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association of Predictive, Preventive and Personalised Medicine. EPMA J 2012; 3: 1-53.
5. Gilbert CA, Slingerland JM. Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. Ann Rev Med 2013; 64: 45-57.
6. Hursting SD, DiGiovanni J, Dannenberg AJ, Azrad M, LeRoith D, Demark-Wahnefried W, et al. Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res 2012; 5: 1260-72.
7. Million M, Angelakis E, Paul M, Armougom F, Leibovici L, Raoult D. Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb Pathog 2012; 53: 100-8.
8. Kang J-H, Yun S-I, Park M-H, Park J-H, Jeong S-Y, Park H-O. Anti-obesity effect of Lactobacillus gasseri BNR17 in highsucrose diet-induced obese mice. PLoS One 2013; 8: e54617.
9. Hamad EM, Sato M, Uzu K, Yoshida T, Higashi S, Kawakami H, et al. Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats. Br J Nutr 2009; 101: 716-24.
10. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007; 104: 979-84.
11. Karimi G, Jamaluddin R, Parvaneh K. The effects of probiotics on body weight and biomarkers of animal. Pakistan J Nutr 2013; 12: 793-9.
12. Zhang Y-J, Li S, Gan R-Y, Zhou T, Xu D-P, Li H-B. Impacts of gut bacteria on human health and diseases. Int J Mol Sci 2015; 16: 7493-519.
13. Geurts L, Neyrinck AM, Delzenne NM, Knauf C, Cani PD. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Benef Microbes 2013; 5: 3-17.
14. Leung J, Burke B, Ford D, Garvin G, Korn C, Sulis C, et al. Possible association between obesity and Clostridium difficile infection. Emerg Infect Dis 2013; 19: 1791.
15. Tanida M, Shen J, Maeda K, Horii Y, Yamano T, Fukushima Y, et al. High-fat diet-induced obesity is attenuated by probiotic strain Lactobacillus paracasei ST11 (NCC2461) in rats. Obes Res Clin Pract 2008; 2: 159-69.
16. Naito E, Yoshida Y, Makino K, Kounoshi Y, Kunihiro S, Takahashi R, et al. Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J Appl Microbiol 2011; 110: 650-7.
17. Matsumoto K, Takada T, Shimizu K, Moriyama K, Kawakami K, Hirano K, et al. Effects of a probiotic fermented milk beverage containing Lactobacillus casei strain Shirota on defecation frequency, intestinal microbiota, and the intestinal environment of healthy individuals with soft stools. J Biosci Bioeng 2010; 110: 547-52.
18. Matsuzaki T. Health properties of milk fermented with Lactobacillus casei strain Shirota (LcS). In: Edward RF, ed. Handbook of fermented functional foods. 2ed ed. Boca Raton, FL: CRC Press; 2003, pp. 165-72.
19. Díaz EG, Folgueras TM. Systematic review of the clinical efficacy of sibutramine and orlistat in weight loss, quality of life and its adverse effects in obese adolescents. Nutr Hosp 2011; 26: 451-7.
20. Núñez IN, Galdeano CM, de Moreno de LeBlanc A, Perdigón G. Lactobacillus casei CRL 431 administration decreases inflammatory cytokines in a diet induced obese mouse model. Nutrition 2015; 31: 1000-7.
21. Firouzi S, Barakatun-Nisak MY, Ismail A, Majid HA, Azmi KN. Role of probiotics in modulating glucose homeostasis: evidence from animal and human studies. Int J Food Sci Nutr 2013; 64: 780-6.
22. Wu C-C, Weng W-L, Lai W-L, Tsai H-P, Liu W-H, Lee M-H, et al. Effect of Lactobacillus plantarum strain K21 on high-fat diet-fed obese mice. Evid Based Complement Alternat Med 2015; 2015: 391767.
23. Yoda K, Sun X, Kawase M, Kubota A, Miyazawa K, Harata G, et al. A combination of probiotics and whey proteins enhances anti-obesity effects of calcium and dairy products during nutritional energy restriction in aP2-agouti transgenic mice. Br J Nutr 2015; 113: 1689-96.
24. Dong H, Rowland I, Yaqoob P. Comparative effects of six probiotic strains on immune function in vitro. Br J Nutr 2012; 108: 459-70.
25. López P, Gueimonde M, Margolles A, Suárez A. Distinct Bifidobacterium strains drive different immune responses in vitro. Int J Food Microbiol 2010; 138: 157-65.
26. Parvaneh K, Jamaluddin R, Karimi G, Erfani R. Effect of probiotics supplementation on bone mineral content and bone mass density. Scientific World Journal 2014; 2014: 595962.
27. Stenman L, Waget A, Garret C, Klopp P, Burcelin R, Lahtinen S. Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice. Benef Microbes 2014; 5: 437-45.
28. Cani PD, Delzenne NM. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol 2009; 9: 737-43.
29. Oelschlaeger TA. Mechanisms of probiotic actions - a review. Int J Med Microbiol 2010; 300: 57-62.
30. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-5.
31. Lee H-Y, Park J-H, Seok S-H, Baek M-W, Kim D-J, Lee K-E, et al. Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochim Biophys Acta 2006; 1761: 736-44.
32. Ahima RS, Flier JS. Leptin. Ann Rev Physiol 2000; 62: 413-37.
33. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32.
34. Sato M, Uzu K, Yoshida T, Hamad EM, Kawakami H, Matsuyama H, et al. Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br J Nutr 2008; 99: 1013-17.
35. Whitehead J, Richards A, Hickman I, Macdonald G, Prins J. Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006; 8: 264-80.
36. Gao X-L, Yang H-X, Zhao Y. Variations of tumor necrosis factor-alpha, leptin and adiponectin in mid-trimester of gestational diabetes mellitus. Chin Med J 2008; 121: 701-5.
37. Feng W, Yuan X, Tong G, Wang W, Hu Y, Shen S, et al. Correlated increase of omentin-and adiponectin by exenatide, avandamet, and dietary change in diet-induced obese rats. Folia Biol (Praha) 2013; 59: 217-24.
38. Kadooka Y, Sato M, Imaizumi K, Ogawa A, Ikuyama K, Akai Y, et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 2010; 64: 636-43.
39. Luoto R, Laitinen K, Nermes M, Isolauri E. Impact of maternal probiotic-supplemented dietary counseling during pregnancy on colostrum adiponectin concentration: a prospective, randomized, placebo-controlled study. Early Hum Dev 2012; 88: 339-44.
40. Nerstedt A, Nilsson EC, Ohlson K, Håkansson J, Thomas Svensson L, Löwenadler B, et al. Administration of Lactobacillus evokes coordinated changes in the intestinal expression profile of genes regulating energy homeostasis and immune phenotype in mice. Br J Nutr 2007; 97: 1117-27.
41. Hulston CJ, Churnside AA, Venables MC. Probiotic supplementation prevents high-fat, overfeeding-induced insulin resistance in human subjects. Br J Nutr 2015; 113: 596-602.
42. Das UN. Is metabolic syndrome X an inflammatory condition? Exp Biol Med 2002; 227: 989-97.
43. Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 2003; 168: 351-8.
44. Bastard J-P, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17: 4-12.
45. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME. Probiotics and immunity. J Gastroenterol 2009; 44: 26-46.
46. Andreasen AS, Sofie A, Larsen N, Pedersen-Skovsgaard T, Berg RM, Møller K, et al. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr 2010; 104: 1831-8.
47. Gøbel RJ, Larsen N, Jakobsen M, Mølgaard C, Michaelsen KF. Probiotics to adolescents with obesity: effects on inflammation and metabolic syndrome. J Pediatr Gastroenterol Nutr 2012; 55: 673-8.
48. Park YH, Kim JG, Shin YW, Kim HS, Kim Y-J, Chun T, et al. Effects of Lactobacillus acidophilus 43121 and a mixture of Lactobacillus casei and Bifidobacterium longum on the serum cholesterol level and fecal sterol excretion in hypercholesterolemiainduced pigs. Biosci Biotechnol Biochem 2008; 72: 595-600.
49. Xiao J, Kondo S, Takahashi N, Miyaji K, Oshida K, Hiramatsu A, et al. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci 2003; 86: 2452-61.
50. Dicker D, Herskovitz P, Katz M, Atar E, Bachar GN. Computed tomography study of the effect of orlistat on visceral adipose tissue volume in obese subjects. Israel Med Assoc J 2010; 12: 199-202.
51. Blackburn GL, Waltman BA. Pharmacotherapy to reduce visceral fat. Clin Cornerstone 2005; 7: 52-60.